Public health
fromwww.theguardian.com
6 days agoCheap supplies of HIV-prevention jab for poorer countries hailed as genuine chance to end' global epidemic
Lenacapavir will be available in 120 low- and middle-income countries from 2027 at $40 per patient per year through generic manufacturers.